Abstract:MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, involved in diverse physiological and pathological processes. An oncogenic or tumor-suppressive miRNA may have potential as a therapeutic target to control cancers. Gefitinib is a tyrosine kinase inhibitor that targets epidermal growth factor receptor (EGFR). H460 and A549 cells with EGFR receptor-independent over-activation of protein kinase B (Akt) or extracellular signal-regulated kinases (ERK) are significantly resistant to gefitinib. The first aim of this study was to confirm a role for three miRNAs (let-7a, hsa-miR-126, and hsa-miR-145) in the inhibition of proliferation in non-small cell lung cancer (NSCLC) cells. A second aim was to evaluate three miRNAs for their abilities to overcome cellular resistance and enhance the gefitinib cytotoxicity. The expression of miRNAs was estimated by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Cell proliferation was examined by sulforhodamine B assay and tumor xenografts were measured in SCID/beige mice. The activation of Akt and ERK was observed by Western blotting. Forced expression of individual miRNA suppressed the growth of two cell lines and xenografts. The effect varied among different miRNAs and cells. Restoration of hsa-miR-126 more obviously inhibited cell growth than did restoration of hsa-miR-145 in both cells, and the suppressive effect was more significant in H460 xenografts than in A549 xenografts. Western blotting revealed that the inhibition of cell proliferation resulted from the inhibition of the activation of Akt and ERK. Moreover, forced expression of miRNAs contributed to enhanced cytotoxicity induced by gefitinib in lung cancer cells; especially in hsa-miR-126, the highest value of half max inhibitory (IC50) was increased sixfold. These findings confirm that tumor-suppressive miRNAs can inhibit the growth of NSCLC cells and enhance the targeted agents cytotoxicity, suggesting novel potential approaches to an improvement in chemotherapy.

Tumor Suppressive Microrna-124A Inhibits Stemness and Enhances Gefitinib Sensitivity of Non-Small Cell Lung Cancer Cells by Targeting Ubiquitin-Specific Protease 14.

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

The Putative Tumour Suppressor Microrna-124 Modulates Hepatocellular Carcinoma Cell Aggressiveness by Repressing Rock2 and Ezh2

MiR-1254 Suppresses HO-1 Expression Through Seed Region-Dependent Silencing and Non-Seed Interaction with TFAP2A Transcript to Attenuate NSCLC Growth

MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.

Microrna-124 Inhibits Proliferation and Induces Apoptosis by Directly Repressing EZH2 in Gastric Cancer

Mir-1246 Promotes Laryngeal Squamous Cell Carcinoma Progression by Interacting with THBS1.

MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.

Mechanism of Hsa-Mirna124-3p Regulating the Proliferation and Migration of Human Lung Cancer Cell Line NCI-H460

Identification of Mir-124A As a Novel Diagnostic and Prognostic Biomarker in Non-Small Cell Lung Cancer for Chemotherapy

The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.

MiR-124 Inhibits Cell Proliferation, Migration and Invasion by Directly Targeting SOX9 in Lung Adenocarcinoma.

miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK.

MicroRNA-30e-5p Inhibits Development and Progression of Non-Small Cell Lung Cancer by Down-Regulating Ubiquitin-Specific Protease 22 Expression

MicroRNA-124 Inhibits Cellular Proliferation and Invasion by Targeting Ets-1 in Breast Cancer

MicroRNA-1253 Suppresses Cell Proliferation and Invasion of Non-Small-cell Lung Carcinoma by Targeting WNT5A

Mir-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1

MicroRNAs Reduce Tumor Growth and Contribute to Enhance Cytotoxicity Induced by Gefitinib in Non-Small Cell Lung Cancer

The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma

Mir‐124 Inhibits Cell Proliferation in Gastric Cancer Through Down‐regulation of SPHK1